While the deletion of Hsp70 did not affect the development ofperipheral neuropathy, the therapeutic efficacy of KU-596 was Hsp70 dependent since, therewere no improvements in MNCV and CMAP. The gene discussed is HSPA4; the disease is neuropathy.